Related Experiment Video
Updated: Jun 23, 2026

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
Published on: May 4, 2015
Pathophysiology of myocardial infarction
Insights
Understanding cellular cholesterol metabolism defects is key for preventing ischemic heart disease deaths. Further research is needed on cellular injury during ischemia.
Area of Science:
- Cardiovascular Science
- Metabolic Research
- Ischemic Heart Disease Pathogenesis
Background:
- Primary prevention of ischemic heart disease (IHD) necessitates a deeper understanding of its underlying mechanisms.
- Current focus on serum lipid levels may be insufficient for identifying and treating atherosclerotic risk.
- Cellular defects in cholesterol metabolism warrant investigation as potential markers.
Purpose of the Study:
- To explore the significance of cellular cholesterol metabolism defects in IHD.
- To investigate the role of coronary spasm in myocardial ischemia.
- To examine strategies for minimizing ischemic injury during cardiopulmonary bypass.
Main Methods:
- Analysis of cellular defects in cholesterol metabolism.
- Evaluation of coronary spasm as a cause of ischemia.
- Manipulation of physiological variables and vasodilator agents during cardiopulmonary bypass.
Main Results:
- Cellular cholesterol metabolism defects may be more indicative of atherosclerotic risk than serum lipids.
- Coronary spasm contributes to ischemia, with or without atherosclerotic lesions.
- Physiological variable manipulation during cardiopulmonary bypass can reduce myocardial oxygen demand-supply imbalance.
Conclusions:
- Cellular cholesterol metabolism defects are crucial for IHD prevention.
- Coronary spasm is a significant factor in ischemic events.
- Further research is required to understand the cellular basis of ischemic injury and irreversible damage.
Abstract:
Primary prevention of death from ischemic heart disease requires further understanding of the pathogenesis of this disorder. Cellular defects of cholesterol metabolism may be more significant markers that serum lipid levels for the identification and treatment of atherosclerotic risk. Coronary spasm has been shown to be an important cause of ischemia in the presence and absence of atherosclerotic lesions. Careful manipulation of physiologic variables with vasodilator agents during cardiopulmonary bypass can substantially alter the myocardial oxygen supply-demand relation, thereby minimizing ischemic injury. The cellular basis for loss of mechanical function during ischemia and the factors that determine irreversible injury are yet unknown.
Related Concept Videos
Pathophysiology of Cardiac Performance
Pathophysiology of Heart Failure
Myocarditis I: Introduction
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Ischemic Stroke ll: Pathophysiology

